litlas
ログインアカウント作成

Yujin Hoshida

2003–2025 年に発表

139
論文数
27,031
被引用数
84
h 指数
128
i10 指数

被引用数

Yujin Hoshida の年別被引用数1994 年: 被引用 1 件1996 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 2 件2004 年: 被引用 5 件2005 年: 被引用 8 件2006 年: 被引用 14 件2007 年: 被引用 25 件2008 年: 被引用 57 件2009 年: 被引用 110 件2010 年: 被引用 191 件2011 年: 被引用 191 件2012 年: 被引用 268 件2013 年: 被引用 244 件2014 年: 被引用 258 件2015 年: 被引用 316 件2016 年: 被引用 296 件2017 年: 被引用 337 件2018 年: 被引用 345 件2019 年: 被引用 1,055 件2020 年: 被引用 1,412 件2021 年: 被引用 1,399 件2022 年: 被引用 1,128 件2023 年: 被引用 976 件2024 年: 被引用 1,527 件2025 年: 被引用 836 件2026 年: 被引用 38 件1995 年は被引用が無いため表示していません1997〜2000 年は被引用が無いため表示していません2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,159 件、この内訳の 22.6%中国: 引用元論文 3,105 件、この内訳の 22.2%イタリア: 引用元論文 632 件、この内訳の 4.5%ドイツ: 引用元論文 629 件、この内訳の 4.5%イギリス: 引用元論文 572 件、この内訳の 4.1%日本: 引用元論文 547 件、この内訳の 3.9%フランス: 引用元論文 527 件、この内訳の 3.8%スペイン: 引用元論文 472 件、この内訳の 3.4%韓国: 引用元論文 357 件、この内訳の 2.5%カナダ: 引用元論文 353 件、この内訳の 2.5%オーストラリア: 引用元論文 263 件、この内訳の 1.9%スイス: 引用元論文 239 件、この内訳の 1.7%
0%22.6%その他 22.4%

機関

分野

  • Medicine57.2%
  • Biochemistry, Genetics and Molecular Biology34.6%
  • Immunology and Microbiology3.5%
  • Computer Science1.2%
  • Neuroscience0.6%
  • Engineering0.5%
  • その他2.4%

トピック

  • Liver Disease Diagnosis and Treatment7.4%
  • Hepatocellular Carcinoma Treatment and Prognosis5.2%
  • Liver physiology and pathology4.1%
  • Ferroptosis and cancer prognosis2.4%
  • RNA modifications and cancer2.1%
  • MicroRNA in disease regulation2%
  • その他76.8%

共著者

全論文

検索で開く
  1. Hepatic stellate cells as key target in liver fibrosis

    著者: Takaaki Higashi, Scott L. Friedman, Yujin Hoshida - Advanced Drug Delivery Reviews 2017 被引用: 1,463

  2. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis

    著者: Aveline Filliol, Yoshinobu Saito, Ajay Nair, Dianne H. Dapito, Le‐Xing Yu, Aashreya Ravichandra, Sonakshi Bhattacharjee, Silvia Affò, Naoto Fujiwara, Hua Su, Qiuyan Sun, Thomas Savage, John R. Wilson‐Kanamori, Jorge Matías Caviglia, LiKang Chin, Dongning Chen, Xiaobo Wang, Stefano Caruso, Jin Ku Kang, Amit Dipak Amin, Sebastian Wallace, Ross Dobie, Deqi Yin, Oscar M. Rodriguez-Fiallos, Chuan Yin, Adam Mehal, Benjamin Izar, Richard A. Friedman, Rebecca G. Wells, Utpal B. Pajvani, Yujin Hoshida, Helen Remotti, Nicholas Arpaia, Jessica Zucman‐Rossi, Michael Karin, Neil C. Henderson, Ira Tabas, Robert F. Schwabe - Nature 2022 被引用: 333

  3. Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development

    著者: Xiaochen Wang, Qifeng He, Chuanli Zhou, Yueyuan Xu, Danhui Liu, Naoto Fujiwara, Naoto Kubota, Arielle Click, Polly Henderson, Janiece Vancil, Cesia A. Marquez, Ganesh Gunasekaran, Myron Schwartz, Parissa Tabrizian, Umut Sarpel, Maria Isabel Fiel, Yarui Diao, Beicheng Sun, Yujin Hoshida, Shuang Liang, Zhenyu Zhong - Immunity 2022 被引用: 233

  4. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer

    著者: Takuma Tsuchida, Youngmin A. Lee, Naoto Fujiwara, Maria D. Ybanez, Brittany N. Allen, Sebastião N. Martins-Filho, Maria Isabel Fiel, Nicolas Goossens, Hsin-I Chou, Yujin Hoshida, Scott L. Friedman - Journal of Hepatology 2018 被引用: 561

  5. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis

    著者: Amit G. Singal, Emily Zhang, Manasa Narasimman, Nicole E. Rich, Akbar K. Waljee, Yujin Hoshida, Ju Dong Yang, María Reig, Giuseppe Cabibbo, Pierre Nahon, Neehar D. Parikh, Jorge A. Marrero - Journal of Hepatology 2022 被引用: 413

  6. Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma

    著者: Yujin Hoshida, Sebastian Nijman, Masahiro Kobayashi, Jennifer A. Chan, Jean-Philippe Brunet, Derek Y. Chiang, Augusto Villanueva, Philippa Newell, Kenji Ikeda, Masaji Hashimoto, Goro Watanabe, Stacey Gabriel, Scott L. Friedman, Hiromitsu Kumada, Josep M. Llovet, Todd R. Golub - Cancer Research 2009 被引用: 1,206

  7. Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma

    著者: James Lally, Sarani Ghoshal, Danielle K. DePeralta, Omeed Moaven, Lan Wei, Ricard Masia, Derek J. Erstad, Naoto Fujiwara, Vivian Leong, Vanessa P. Houde, Alexander Anagnostopoulos, Alice Wang, Lindsay A. Broadfield, Rebecca J. Ford, Robert A. Foster, Jamie Bates, Hailing Sun, Ting Wang, Henry Liu, Adrian S. Ray, Asish K. Saha, Jeremy R. Greenwood, Sathesh Bhat, Geraldine Harriman, Wenyan Miao, Jennifer L. Rocnik, William Westlin, Paola Muti, Theodoros Tsakiridis, H. James Harwood, Rosana Kapeller, Yujin Hoshida, Kenneth K. Tanabe, Gregory R. Steinberg, Bryan C. Fuchs - Cell Metabolism 2018 被引用: 409

  8. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

    著者: Amon Asgharpour, Sophie C. Cazanave, Tommy Pacana, Mulugeta Seneshaw, Robert Vincent, Bubu A. Banini, Divya P. Kumar, Kalyani Daita, Hae‐Ki Min, Faridoddin Mirshahi, Pierre Bédossa, Xiaochen Sun, Yujin Hoshida, Srinivas V. Koduru, Daniel Contaifer, Urszula Osinska Warncke, Dayanjan S. Wijesinghe, Arun J. Sanyal - Journal of Hepatology 2016 被引用: 533

  9. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine

    著者: Naoto Fujiwara, Scott L. Friedman, Nicolas Goossens, Yujin Hoshida - Journal of Hepatology 2017 被引用: 683

  10. Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets

    著者: Yujin Hoshida, Jean-Philippe Brunet, Pablo Tamayo, Todd R. Golub, Jill P. Mesirov - PLoS ONE 2007 被引用: 671

  11. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma

    著者: Shlomi Finkin, Detian Yuan, Ilan Stein, Koji Taniguchi, Achim Weber, Kristian Unger, Jeffrey L. Browning, Nicolas Goossens, Shigeki Nakagawa, Ganesh Gunasekaran, Myron Schwartz, Masahiro Kobayashi, Hiromitsu Kumada, Michael Berger, Orit Pappo, Klaus Rajewsky, Yujin Hoshida, Michael Karin, Mathias Heikenwälder, Yinon Ben‐Neriah, Eli Pikarsky - Nature Immunology 2015 被引用: 419

  12. Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma

    著者: Derek Y. Chiang, Augusto Villanueva, Yujin Hoshida, Judit Peix, Philippa Newell, Beatriz Mínguez, Amanda C. LeBlanc, Diana Donovan, Swan N. Thung, Manel Solé, Victoria Tovar, Clara Alsinet, Alex H. Ramos, Jordi Barretina, Sasan Roayaie, Myron Schwartz, Samuel Waxman, Jordi Bruix, Vincenzo Mazzaferro, Azra H. Ligon, Vesna Najfeld, Scott L. Friedman, William R. Sellers, Matthew Meyerson, Josep M. Llovet - Cancer Research 2008 被引用: 713

  13. Nearest Template Prediction: A Single-Sample-Based Flexible Class Prediction with Confidence Assessment

    著者: Yujin Hoshida - PLoS ONE 2010 被引用: 427

  14. Risk stratification and early detection biomarkers for precision HCC screening

    著者: Yi‐Te Lee, Naoto Fujiwara, Ju Dong Yang, Yujin Hoshida - Hepatology 2022 被引用: 111

  15. Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis

    著者: Satoshi Kawamura, Yuki Matsushita, Shigeyuki Kurosaki, Mizuki Tange, Naoto Fujiwara, Yuki Hayata, Yoku Hayakawa, Nobumi Suzuki, Masahiro Hata, Mayo Tsuboi, Takahiro Kishikawa, Hiroto Kinoshita, Takuma Nakatsuka, Masaya Sato, Yotaro Kudo, Yujin Hoshida, Atsushi Umemura, Akiko Eguchi, Tsuneo Ikenoue, Yoshihiro Hirata, Motonari Uesugi, Ryosuke Tateishi, Keisuke Tateishi, Mitsuhiro Fujishiro, Kazuhiko Koike, Hayato Nakagawa - Journal of Clinical Investigation 2022 被引用: 108

  16. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity

    著者: Naoto Fujiwara, Hayato Nakagawa, Kenichiro Enooku, Yotaro Kudo, Yuki Hayata, T. Nakatsuka, Yasuo Tanaka, Ryosuke Tateishi, Yohko Hikiba, Kento Misumi, Mariko Tanaka, Akimasa Hayashi, Junji Shibahara, Masashi Fukayama, Junichi Arita, Kiyoshi Hasegawa, Hadassa Hirschfield, Yujin Hoshida, Yoshihiro Hirata, Motoyuki Otsuka, Keisuke Tateishi, Kazuhiko Koike - Gut 2018 被引用: 223

  17. Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes

    著者: Daniela Sia, Yujin Hoshida, Augusto Villanueva, Sasan Roayaie, Joana Ferrer, Barbara Tabak, Judit Peix, Manel Solé, Victoria Tovar, Clara Alsinet, Helena Cornellà, Brandy Klotzle, Jian‐Bing Fan, Christian Cotsoglou, Swan N. Thung, Josep Fuster, Samuel Waxman, Juan Carlos García‐Valdecasas, Jordi Bruix, Myron Schwartz, Rameen Beroukhim, Vincenzo Mazzaferro, Josep M. Llovet - Gastroenterology 2013 被引用: 588

  18. Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma

    著者: Julien Bollard, Verónica Miguela, Marina Ruiz de Galarreta, Anu Venkatesh, C. Billie Bian, Mark P. Roberto, Victoria Tovar, Daniela Sia, Pedro Molina-Sánchez, Christie B. Nguyen, Shigeki Nakagawa, Josep M. Llovet, Yujin Hoshida, Amaia Lujambio - Gut 2016 被引用: 297

  19. Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease

    著者: Zixi Wang, Shijia Zhu, Yuemeng Jia, Yunguan Wang, Naoto Kubota, Naoto Fujiwara, Ruth Gordillo, Cheryl Lewis, Min Zhu, Tripti Sharma, Lin Li, Qiyu Zeng, Yu-Hsuan Lin, Meng-Hsiung Hsieh, Purva Gopal, Tao Wang, Matt Hoare, Peter J. Campbell, Yujin Hoshida, Hao Zhu - Cell 2023 被引用: 75

  20. Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

    著者: Yujin Hoshida, Augusto Villanueva, Masahiro Kobayashi, Judit Peix, Derek Y. Chiang, Amy L. Camargo, Supriya Gupta, Jamie Moore, Matthew J. Wrobel, Jim Lerner, Michael Reich, Jennifer A. Chan, Jonathan N. Glickman, Kenji Ikeda, Masaji Hashimoto, Goro Watanabe, Maria Grazia Daidone, Sasan Roayaie, Myron Schwartz, Swan N. Thung, Helga B. Salvesen, Stacey Gabriel, Vincenzo Mazzaferro, Jordi Bruix, Scott L. Friedman, Hiromitsu Kumada, Josep M. Llovet, Todd R. Golub - New England Journal of Medicine 2008 被引用: 1,289

  21. International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance

    著者: Amit G. Singal, Marco Sanduzzi‐Zamparelli, Pierre Nahon, Maxime Ronot, Yujin Hoshida, Nicole E. Rich, María Reig, Valérie Vilgrain, Jorge A. Marrero, Josep M. Llovet, Neehar D. Parikh, Augusto Villanueva - Journal of Hepatology 2023 被引用: 86

  22. DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma

    著者: Augusto Villanueva, Anna Portela, Sergi Sayols, Carlo Battiston, Yujin Hoshida, Jesús Méndez‐González, Sandrine Imbeaud, Éric Letouzé, Virginia Hernández–Gea, Helena Cornellà, Roser Pinyol, Manel Solé, Josep Fuster, Jessica Zucman‐Rossi, Vincenzo Mazzaferro, Manel Esteller, Josep M. Llovet - Hepatology 2015 被引用: 446

  23. Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

    著者: Naoto Fujiwara, Naoto Kubota, Émilie Crouchet, Bhuvaneswari Koneru, Cesia A. Marquez, Arun Kumar Jajoriya, Gayatri Panda, Tongqi Qian, Shijia Zhu, Nicolas Goossens, Xiaochen Wang, Shuang Liang, Zhenyu Zhong, Sara Lewis, Bachir Taouli, Myron Schwartz, Maria Isabel Fiel, Amit G. Singal, Jorge A. Marrero, Austin J. Fobar, Neehar D. Parikh, Indu Raman, Quan‐Zhen Li, Masataka Taguri, Atsushi Ono, Hiroshi Aikata, Takashi Nakahara, Hayato Nakagawa, Yuki Matsushita, Ryosuke Tateishi, Kazuhiko Koike, Masahiro Kobayashi, Takaaki Higashi, Shigeki Nakagawa, Yo‐ichi Yamashita, Toru Beppu, Hideo Baba, Hiromitsu Kumada, Kazuaki Chayama, Thomas F. Baumert, Yujin Hoshida - Science Translational Medicine 2022 被引用: 115

  24. Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis

    著者: Tracey G. Simon, Robert M. Wilechansky, Stefania Stoyanova, Alessandra Grossman, Laura E. Dichtel, Georg M. Lauer, Karen K. Miller, Yujin Hoshida, Kathleen E. Corey, Rohit Loomba, Raymond T. Chung, Andrew T. Chan - JAMA 2024 被引用: 83